These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23458597)

  • 1. Should physicians rely on pharmaceutical detailing for their education?
    van Schalkwyk JM; Turner MJ
    J Clin Hypertens (Greenwich); 2013 Mar; 15(3):218. PubMed ID: 23458597
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppressing commercial speech is not in the best interests of physicians and patients.
    Chressanthis G; Khedkar P; Jain N; Poddar P; Seiders M
    J Clin Hypertens (Greenwich); 2013 Mar; 15(3):219-20. PubMed ID: 23458598
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug detailing in academic medical centers: regulating for the right reasons, with the right evidence, at the right time.
    Steinman MA; Schillinger D
    Am J Bioeth; 2010 Jan; 10(1):21-3. PubMed ID: 20077331
    [No Abstract]   [Full Text] [Related]  

  • 4. Can access limits on sales representatives to physicians affect clinical prescription decisions? A study of recent events with diabetes and lipid drugs.
    Chressanthis GA; Khedkar P; Jain N; Poddar P; Seiders MG
    J Clin Hypertens (Greenwich); 2012 Jul; 14(7):435-46. PubMed ID: 22747616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doctors behaving badly?
    Tattersall MH; Kerridge IH
    Med J Aust; 2006 Sep; 185(6):299-300. PubMed ID: 16999666
    [No Abstract]   [Full Text] [Related]  

  • 6. Physician Exposure to Direct-to-Consumer Pharmaceutical Marketing: Potential for Creating Prescribing Bias.
    Brown JL
    Am J Med; 2017 Jun; 130(6):e247-e248. PubMed ID: 28089801
    [No Abstract]   [Full Text] [Related]  

  • 7. Conflict of interest: the elephant in your practice.
    Kaliski S
    Afr J Psychiatry (Johannesbg); 2013 May; 16(3):161, 163, 165. PubMed ID: 23739815
    [No Abstract]   [Full Text] [Related]  

  • 8. [Editorial: Hebebrand, J., Blanz, B., Herpertz-Dahlmann, B. & Lehmkuhl, G. 2012. Increase in the abundance of medical treatments, ethical principles and conflicts of interest in cooperation with the pharmaceutical industry].
    Frank R
    Z Kinder Jugendpsychiatr Psychother; 2013 Mar; 41(2):145-9. PubMed ID: 23425616
    [No Abstract]   [Full Text] [Related]  

  • 9. Take this medicine: the legality of prescription incentive schemes.
    Fanning J; Glover-Thomas N
    Med Law Rev; 2010; 18(3):417-26. PubMed ID: 20739438
    [No Abstract]   [Full Text] [Related]  

  • 10. [Conflicts of interest: an academic proposal].
    Lama A
    Rev Med Chil; 2006 Jun; 134(6):800. PubMed ID: 17130959
    [No Abstract]   [Full Text] [Related]  

  • 11. No more free lunches.
    Abbasi K; Smith R
    BMJ; 2003 May; 326(7400):1155-6. PubMed ID: 12775587
    [No Abstract]   [Full Text] [Related]  

  • 12. Doping Doctors: The Influence of the Marketing Departments of Pharmaceutical Companies on Physician and Researcher Behavior in Japan.
    Ichikawa I; Clayton EW
    Account Res; 2016; 23(4):245-53. PubMed ID: 26829657
    [No Abstract]   [Full Text] [Related]  

  • 13. Financial incentives and the prescription of newer vaccines by doctors in India.
    Lodha R; Bhargava A
    Indian J Med Ethics; 2010; 7(1):28-30. PubMed ID: 20166294
    [No Abstract]   [Full Text] [Related]  

  • 14. The baby with the bathwater.
    Buyske J
    Arch Surg; 2010 Jun; 145(6):577. PubMed ID: 20575190
    [No Abstract]   [Full Text] [Related]  

  • 15. [Conflicts of interest, an insidious blight on medicine].
    Altisent R
    Aten Primaria; 2019 Oct; 51(8):469-470. PubMed ID: 31202475
    [No Abstract]   [Full Text] [Related]  

  • 16. [Conflicts of interest in the medical profession].
    Altisent R; Delgado-Marroquín MT; Astier-Peña MP
    Aten Primaria; 2019 Oct; 51(8):506-511. PubMed ID: 31248656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru.
    De Ferrari A; Gentille C; Davalos L; Huayanay L; Malaga G
    PLoS One; 2014; 9(6):e100114. PubMed ID: 24978481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribers and pharmaceutical representatives: why are we still meeting?
    Fischer MA; Keough ME; Baril JL; Saccoccio L; Mazor KM; Ladd E; Von Worley A; Gurwitz JH
    J Gen Intern Med; 2009 Jul; 24(7):795-801. PubMed ID: 19424764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conflicts of interest in clinical practice. Ethical analysis of some relationships with the pharmaceutical industry].
    Salas SP; Osorio F M; Vial C P; Rehbein V AM; Salas A C; Beca I JP
    Rev Med Chil; 2006 Dec; 134(12):1576-82. PubMed ID: 17277877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixing Dinner and Drugs-Is It Ethically Contraindicated?
    Essi DF
    AMA J Ethics; 2015 Aug; 17(8):787-95. PubMed ID: 26270881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.